They demonstrated that the IG DCIS shared more features with well-differed than poorly differentiated DCIS and show that the Bcl-2-positive luminal subgroup may indicate a more favourable group of lesions. The gene discussed is BCL2; the disease is ductal breast carcinoma in situ.